SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 230 filers reported holding SAGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $38,237,000 | -33.6% | 442,000 | -53.1% | 0.08% | -42.4% |
| Q3 2020 | $57,575,000 | +1494.9% | 942,000 | +1784.0% | 0.14% | +1500.0% |
| Q4 2019 | $3,610,000 | +28.7% | 50,000 | +150.0% | 0.01% | +28.6% |
| Q3 2019 | $2,806,000 | -23.4% | 20,000 | 0.0% | 0.01% | -22.2% |
| Q2 2019 | $3,662,000 | +15.1% | 20,000 | 0.0% | 0.01% | +12.5% |
| Q1 2019 | $3,181,000 | -85.5% | 20,000 | -85.0% | 0.01% | -84.0% |
| Q4 2017 | $21,906,000 | – | 133,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 181,650 | $15,715,000 | 7.17% |
| GREAT POINT PARTNERS LLC | 454,417 | $39,312,000 | 6.38% |
| ACUTA CAPITAL PARTNERS, LLC | 255,800 | $22,129,000 | 6.02% |
| Integral Health Asset Management, LLC | 195,000 | $16,869,000 | 5.02% |
| DAFNA Capital Management LLC | 181,306 | $15,685,000 | 4.67% |
| Boxer Capital, LLC | 1,094,000 | $94,642,000 | 3.04% |
| Palo Alto Investors LP | 590,200 | $51,058,000 | 2.68% |
| Bellevue Group AG | 1,567,504 | $135,604,000 | 1.55% |
| Aristotle Atlantic Partners, LLC | 160,805 | $13,911,000 | 1.07% |
| JGP Global Gestao de Recursos Ltda. | 2,618 | $226,000 | 0.85% |